NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-210-2018-0-EP-03 CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY EP National Stage 20718061.3 Pending
NIAID E-095-2019-0-EP-03 HIV RNA VACCINES EP National Stage 20773323.9 Pending
NCI E-181-2017-0-IL-14 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS IL National Stage 273254 Issued
NIAMS E-192-2017-0-CN-03 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF HEPATITIS B VIRUS INFECTION CN National Stage 201880059238.8 Abandoned
NIAID E-168-2020-1-US-01 Corona Virus Binders US 62/988,610 Expired
NCI E-075-2020-0-US-01 SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES US 62/988,783 Abandoned
NCATS E-118-2019-0-JP-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF JP National Stage 2021-563609 Issued
NCATS E-118-2019-0-IT-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF IT EP 20794764.9 Issued
NCATS E-118-2019-0-DE-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF DE EP 20794764.9 Issued
NCATS E-118-2019-0-IE-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF IE EP 20794764.9 Issued
NCATS E-118-2019-0-ES-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF ES EP 20794764.9 Issued
NCATS E-118-2019-0-FR-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF FR EP 20794764.9 Issued
NCATS E-118-2019-0-GB-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF GB EP 20794764.9 Issued
NCATS E-118-2019-0-EP-03 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF EP National Stage 20794764.9 Issued
NCI E-190-2014-0-AU-45 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS AU DIV 2020201799 Issued
NCI E-080-2020-0-US-01 USE OF ISOVALERYLSPIRAMYCINS AS ANTI-CANCER AGENTS TO INHIBIT METASTASIS US ORD 16/816,068 11351185 Issued PDF
NCATS E-118-2019-0-PCT-02 SMALL MOLECULE BROMODOMAIN INHIBITORS AND USES THEREOF PCT PCT PCT/US2020/022072 Expired
NCATS E-004-2016-1-US-01 Substituted Bicyclic Heteroaryl Inhibitors Of Bromodomain-containing Protein BRD4 US 62/988,206 Abandoned
NCATS E-118-2019-0-AU-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF AU National Stage 2020264106 Pending
NCATS E-118-2019-0-CA-04 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF CA National Stage 3137870 Pending
NCI E-250-2014-0-US-08 ANTI-CD276 ANTIBODIES (B7H3) US DIV 16/812,980 11851498 Issued PDF
NIDDK E-081-2019-0-PC-01 Method For Improving Insulin Sensitivity PCT PCT PCT/US2020/000009 Expired
NCI E-230-2012-0-US-58 T CELL RECEPTORS RECOGNIZING MHC CLASS II-RESTRICTED MAGE-A3 US DIV 16/812,845 Abandoned
NIDDK E-081-2019-0-EP-01 Method For Improving Insulin Sensitivity EP National Stage 20774479.8 Pending
NIDDK E-081-2019-0-KR-01 METHOD OF PRODUCING MODIFIED AMYLOID PRECURSOR PROTEIN ANCHORED WITH DETECTABLE MOIETIES AND MODIFIED AMYLOID PEPTIDES DERIVED THEREOF KR National Stage 10-2021-7033113 Pending
NIDDK E-081-2019-0-AU-01 METHOD OF IMPROVING INSULIN SENSITIVITY AU National Stage 2020239920 Pending
NIAID E-131-2020-0-US-01 Anti-Coronavirus Antibodies And Methods Of Use US 62/987,313 Abandoned
NCI E-207-2017-1-PCT-02 ADAM17 BINDING MOLECULES AND USES THEREOF PCT PCT PCT/US2020/021603 Expired
NCI E-207-2017-1-US-02 ADAM17 BINDING MOLECULES AND USES THEREOF US National Stage 17/437,065 Pending
NCI E-207-2017-1-EP-03 ADAM17 BINDING MOLECULES AND USES THEREOF EP National Stage 20769619.6 Pending
NHLBI E-085-2019-0-PCT-01 METHODS FOR ASSESSING CARDIOVASCULAR DISEASE OR INFLAMMATORY DISEASE RISK USING NON-EXCHANGEABLE LIPID PROBE PCT PCT COMB PCT/US2020/021494 Expired
NIAID E-052-2021-0-US-01 Engineered Influenza Neuraminidase Antigens US 62/986,295 Abandoned
NIDDK E-043-2020-0-US-01 RNA Target Enrichment or Depletion of Biological Supplies US 62/986,055 Abandoned
NCI E-241-2016-0-US-06 Micro-Dose Calibrator US National Stage 16/644,441 11029418 Issued PDF
NIBIB E-076-2020-0-US-01 Fluorescence Scanning System For Analytical Ultracentrifugation US 62/985,222 Abandoned
NCI E-040-2012-0-KR-47 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen KR DIV 10-2020-7006131 Issued
NIA E-013-2010-0-US-16 THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS US CON 16/806,659 10925840 Issued PDF
NCI E-205-2010-2-JP-19 Photosensitizing Antibody-Flurophore Conjugates JP DIV 2020-035079 Pending
NCATS E-077-2020-2-US-01 SUBSTITUTED IMIDAZO[1,2-a]PYRIDINES AS IRAK 1/4 AND FLT3 INHIBITORS US CIP 16/804,518 11542261 Abandoned PDF
NIA E-249-2016-0-HK-17 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM HK National Stage 62020003496.0 Pending
NHGRI E-180-2020-0-US-01 METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING IMMUNITY TO VIRAL TRANSFER VECTORS US 62/981,564 Abandoned
NHGRI E-179-2020-0-US-01 METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING
IMMUNITY TO VIRAL TRANSFER VECTORS 		US 62/981,555 Abandoned
NCI E-088-2020-0-US-01 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION US 62/981,856 Abandoned
NHGRI E-149-2017-0-US-04 BIOMARKERS OF ORGANIC ACIDEMIAS US National Stage 16/641,994 11372004 Issued PDF
NCI E-137-2019-0-US-01 METHODS OF TREATING DIFFUSE LARGE B CELL LYMPHOMA BASED ON PARTICULAR GENETIC SUBTYPE US 62/981,382 Abandoned
NCI E-238-2015-0-HK-09 MOLECULAR NANOTAGS HK CN 62020003242.8 Issued
NHLBI E-090-2020-0-US-01 NK CELLS OR T CELLS EXPRESSING HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE US 62/980,854 Abandoned
NIAID E-236-2018-0-US-03 Monoclonal Antibody Against Spike Protein Of Middle East Respiratory Syndrome Coronavirus And Uses Thereof US National Stage 16/641,580 Abandoned
NCI E-234-2014-1-AU-01 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF AU DIV 2020201292 Issued
NCATS E-168-2019-0-US-01 RADIAL GLIA AND ASTROCYTE DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS US 62/979,429 Abandoned